BMS-986010
BMS-986010 is a monoclonal antibody inhibitor targeting the p19 subunit of interleukin-23 (IL-23) . BMS-986010 reduces IL-23-induced STAT3 phosphorylation and inhibits Th17 cell differentiation and the release of proinflammatory cytokines (such as IL-17 and TNF-α) . BMS-986010 is promising for research of autoimmune diseases such as psoriasis and Crohn's disease[1].
Product Specifications
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[BMS-986010]
References & Citations
[1]Li J, et al. Mapping the Energetic Epitope of an Antibody/Interleukin-23 Interaction with Hydrogen/Deuterium Exchange, Fast Photochemical Oxidation of Proteins Mass Spectrometry, and Alanine Shave Mutagenesis. Anal Chem. 2017 Feb 21;89 (4) :2250-2258.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
IL-23
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041845-500 1x 500 µL
Aurora B (Proliferation Marker) (AURKB/1845), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB1017-100 1x 100 µL
SOX10 (SOX10/1074), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 